Pharmalittle: Roche investing in U.S.; estrogen patch shortage
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
In surprise move, FDA rejects cancer drug expected to rival Novartis therapy
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…
Oak Hill Bio to take on Ultragenyx, Ionis in Angelman syndrome
RA Capital and a fleet of other investors are putting $175 million behind Oak Hill Bio, a startup…
Pharmalittle: Novartis buys Myricx Bio, GOP backs trial diversity
Good morning, and welcome to a new week from STAT’s London outpost, with Andrew Joseph here filling in…
Roche pharmaceuticals CEO Bill Anderson to step down
Roche announced Monday that Bill Anderson, CEO of its pharmaceuticals division, will step down after nearly four years…
Roche to acquire startup PathAI for $750 million upfront
Roche has signed a deal to pay $750 million upfront for Boston-based PathAI, an acquisition by the Swiss…
Pharmalittle: Medicare drops obesity drug pilot, Roche touts MS data
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and…
Roche set to take its MS drug to regulators, but safety questions loom
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Roche to launch another Elevidys trial, hoping to win E.U. approval
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Roche is fined by Romania for thwarting competition to its cancer drugs
Following a two-year investigation, Roche (RHHBY) was fined $14 million by antitrust authorities in Romania for using different…
Novartis buys Synnovation breast cancer drug for $2B
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Roche suffers a fresh blow as India’s Supreme Court allows generic sales of its pricey rare disease drug
In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which…